{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:52:01Z","timestamp":1789386721798,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31300151"],"award-info":[{"award-number":["31300151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.074","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T14:04:48Z","timestamp":1396620288000},"page":"2675-2681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2"],"prefix":"10.1016","volume":"32","author":[{"given":"Dong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Ya","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.03.074_bib0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11481-010-9234-7","article-title":"Arboviral encephalitides: transmission, emergence, and pathogenesis","volume":"5","author":"Hollidge","year":"2010","journal-title":"J Neuroimmune Pharmacol: Off J Soc Neuroimmune Pharmacol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0010","first-page":"49","article-title":"Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia","volume":"267","author":"Mackenzie","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0015","first-page":"11","article-title":"Japanese encephalitis virus: ecology and epidemiology","volume":"267","author":"Endy","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0020","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0030","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","article-title":"Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants","volume":"26","author":"Gatchalian","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0035","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMc0808664","article-title":"Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis","volume":"360","author":"Kumar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0045","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"Domingo","year":"2012","journal-title":"Microbiol Mol Biol Rev: MMBR"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0055","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1099\/vir.0.043844-0","article-title":"A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1\u2019 formation and contributes to attenuation","volume":"93","author":"Ye","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0060","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.vaccine.2013.12.050","article-title":"Recombinant chimeric Japanese encephalitis virus\/tick-borne encephalitis virus is attenuated and protective in mice","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0065","doi-asserted-by":"crossref","first-page":"13694","DOI":"10.1128\/JVI.00931-13","article-title":"A chimeric dengue virus vaccine using japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0070","first-page":"119","article-title":"Experience with the Vero cell line","volume":"93","author":"Montagnon","year":"1998"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14712590903042282","article-title":"IC51 Japanese encephalitis vaccine","volume":"9","author":"Kollaritsch","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2014.03.074_bib0080","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1099\/vir.0.059436-0","article-title":"Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2","volume":"94","author":"Li","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","article-title":"Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0090","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.str.2004.04.024","article-title":"West Nile virus core protein; tetramer structure and ribbon formation","volume":"12","author":"Dokland","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0095","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0305892101","article-title":"Solution structure of dengue virus capsid protein reveals another fold","volume":"101","author":"Ma","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0100","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.02653-08","article-title":"Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virions","volume":"83","author":"Schlick","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0105","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/JVI.02120-06","article-title":"Functional requirements of the yellow fever virus capsid protein","volume":"81","author":"Patkar","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0110","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/JVI.76.7.3534-3543.2002","article-title":"Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence","volume":"76","author":"Kofler","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0115","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1128\/JVI.75.20.9731-9740.2001","article-title":"Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice","volume":"75","author":"Blaney","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/viro.2002.1528","article-title":"Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells","volume":"300","author":"Blaney","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0125","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0264-410X(03)00487-0","article-title":"Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2\/4 vaccine candidate in Vero cells","volume":"21","author":"Blaney","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0130","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1348-0421.2005.tb03719.x","article-title":"Molecular basis for adaptation of a chimeric dengue type-4\/Japanese encephalitis virus to Vero cells","volume":"49","author":"Tang","year":"2005","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virusres.2013.04.003","article-title":"Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes","volume":"176","author":"Beasley","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0145","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1128\/JVI.01083-09","article-title":"Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques","volume":"83","author":"Anez","year":"2009","journal-title":"J Virol"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2014.03.074_bib0150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1099\/0022-1317-76-4-865","article-title":"Neurovirulence and neuroinvasiveness of Murray Valley encephalitis virus mutants selected by passage in a monkey kidney cell line","volume":"76","author":"McMinn","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-422X-5-27","article-title":"Constancy and diversity in the flavivirus fusion peptide","volume":"5","author":"Seligman","year":"2008","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0160","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0165","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0170","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0175","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever Virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0180","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1099\/vir.0.80638-0","article-title":"Characterization of the E-138 (Glu\/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone","volume":"86","author":"Zhao","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2006.05.025","article-title":"A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus","volume":"353","author":"Zhang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0190","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.vaccine.2009.03.007","article-title":"A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0195","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/171.5.1144","article-title":"Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA","volume":"171","author":"Sumiyoshi","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.1996.0457","article-title":"Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro","volume":"223","author":"Chen","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0205","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1128\/JVI.78.15.8271-8280.2004","article-title":"protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses","volume":"78","author":"Lee","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0210","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2009.02.074","article-title":"In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB)","volume":"27","author":"Knowles","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0215","doi-asserted-by":"crossref","first-page":"e25800","DOI":"10.1371\/journal.pone.0025800","article-title":"Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmv.20889","article-title":"Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene","volume":"79","author":"Laassri","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2014.03.074_bib0225","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1128\/JVI.03351-13","article-title":"Stability of the parainfluenza virus 5 genome revealed by deep sequencing of strains isolated from different hosts and following passage in cell culture","volume":"88","author":"Rima","year":"2014","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T04:52:04Z","timestamp":1538715124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":45,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004551"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}